MetLife Investment Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $610K | Hold |
|
|||||
|
2025
Q1 | $588K | Sell |
|
|||||
|
2024
Q4 | $849K | Buy |
|
|||||
|
2024
Q3 | $828K | Hold |
|
|||||
|
2024
Q2 | $473K | Buy |
|
|||||
|
2024
Q1 | $448K | Buy |
|
|||||
|
2023
Q4 | $485K | Hold |
|
|||||
|
2023
Q3 | $342K | Hold |
|
|||||
|
2023
Q2 | $530K | Buy |
|
|||||
|
2023
Q1 | $505K | Hold |
|
|||||
|
2022
Q4 | $580K | Buy |
|
|||||
|
2022
Q3 | $281K | Hold |
|
|||||
|
2022
Q2 | $159K | Buy |
|